Ranitidine RAXIDINE 25mg/mL IV 2ml x 10 ampoules

Description

Ranitidine RAXIDINE 25mg/mL IV 2ml x 10 ampuoules

FORMULATION: Each mL contains: Ranitidine hydrochloride, USP Equivalent to: Ranitidine 25 mg With preservatives: Phenol 5 mg

INDICATION: For the treatment of duodenal ulcer, benign gastric ulcer, post-operative ulcer, and of Zollinger-Ellison Syndrome. Used in the management of conditions where reduction of gastric secretion and acid output is desirable, such as reflux esophagitis and prophylaxis against gastrointestinal haemorrhage from stress ulceration in seriously ill patients, recurrent haemorrhage in patients with bleeding peptic ulcers and acid aspiration (Mendelson’s Syndrome) before anaesthesia in patients at risk, particularly obstetric patients during labour).

DOSAGE AND ADMINISTRATION: In Slow IV injection (over at least 2 minutes) of 50 mg, after dilution to a volume of 20 mL per 50 mg dose. This dose may be repeated every 6 to 8 hours. An intermittent I.V. infusion at a rate of 25 mg per hour for 2 hours. The infusion may be repeated at 6 to 8 hours intervals. In I.M. injection of 50 mg (2mL) every 6 to 8 hours.